United States Joins Suit against Navistar Defense LLC Alleging False Claims under Marine Corps Contract

Washington, DC - The United States has intervened in a whistleblower suit filed in the United States District Court for the District of Columbia against Navistar Defense LLC.  Navistar Defense manufactured armored vehicles for the United States military and is a subsidiary of Navistar International LLC, headquartered in Melrose Park, Illinois. 

Justice Department Announces More than $376 Million in Awards to Promote Public Safety

Washington, DC - The Department of Justice’s Office of Justice Programs (OJP) Wednesday announced that it has awarded more than $376 million in grant funding to enhance state, local and tribal law enforcement operations and reinforce public safety efforts in jurisdictions across the United States.

Hizballah Operative Sentenced to 40 Years in Prison for Covert Terrorist Activities on Behalf of Hizballah’s Islamic Jihad Organization

New York - The Department of Justice Tuesday announced that Ali Kourani, 35, was sentenced to 40 years in prison based on terrorism, sanctions, and immigration convictions arising from Kourani’s illicit work as an operative for the Islamic Jihad Organization, Hizballah’s external attack-planning component.

Four Gangster Disciples Sentenced Following Seven-Week Jury Trial

Clarksville, Tennessee - Following a seven-week jury trial in U.S. District Court earlier this year, a federal jury convicted five members of the Gangster Disciples of multiple counts relating to a racketeering conspiracy and a drug distribution conspiracy, which plagued the Clarksville, area with violence and murders for more than a decade, announced Assistant Attorney General Brian A. Benczkowski of the Justice Department’s Criminal Division and U.S. Attorney Don Cochran for the Middle District of Tennessee.

Second Pharmaceutical Company Admits to Price Fixing, Resolves Related False Claims Act Violations

Washington, DC - Rising Pharmaceuticals Inc. (Rising), a generic pharmaceutical company headquartered in New Jersey, was charged for conspiring to fix prices and allocate customers for a generic hypertension drug, the Department of Justice announced Tuesday.